Skip to main content

ROYAL BANK OF CANADA

Bank

Position in ENGN — enGene Therapeutics Inc.

CIK 1000275 TORONTO, A6

Position in ENGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,591
-$52,220 QoQ
Shares Held
11,325
+7.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 60 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 30% Shared 70% None 0%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ENGN ranks #237 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,591 11,325
2026-03-31 $71,811 10,545
2025-12-31 $71,472 7,915
2025-09-30 $54,059 7,915
2025-06-30 $28,810 7,915
2025-03-31 $35,459 7,915
2024-12-31 $52,634 7,915
2024-09-30 $52,239 7,915
2024-06-30 $74,638 7,915
2024-03-31 $134,159 7,915
2023-12-31 $349,309 37,845